BAE Systems has received a USD 184 million (EUR 168 million) contract modification to produce an additional 48 Armored Multi-Purpose Vehicles (AMPVs) for the US Army, the company announced on 9 October 2024.
The order is in addition to the existing full-rate production contract for the vehicle.
The AMPV family of vehicles replaces the US Army’s legacy M113 armoured personnel carrier-based AFVs and “modernises the force by providing critical survivability, mobility, onboard power and interoperability upgrades to the Armored Brigade Combat Team”, according to BAE Systems. The AMPV family is currently built in five variants, including the General Purpose, Mortar Carrier, Medical Evacuation, Medical Treatment, and Mission Command vehicles.
“Soldiers deserve advanced capabilities like the AMPV that have been successfully tested to accomplish the many mission roles they will serve in the formation,” Bill Sheehy, AMPV programme director for BAE Systems, was quoted as saying in a company press release. “It’s remarkable to have advanced to this stage of full-rate production. We value our continued partnerships with the army and our suppliers who work alongside us to ensure we keep producing these critical combat vehicles at higher, sustainable volumes.”
In addition to full-rate production efforts, BAE Systems will soon finalise a large-scale expansion effort in York, Pennsylvania, which includes the AMPV production line. The expansion and multi-faceted engineering work across the company’s industrial network provides the capacity and technology necessary to deliver the vehicles at greater rates for the US and potential international customers.
Beyond York, Pennsylvania, work on the AMPV programme also takes place across BAE Systems’ industrial network, which includes facilities in Aiken, South Carolina; Anniston, Alabama; Phoenix, Arizona; and Sterling Heights, Michigan.
